Patients who underwent photorefractive keratectomy had stable visual quality and refraction 10 years after surgery, a study showed.
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-Month, Randomized, Controlled, Double-masked, Multicenter Phase II Study
Ranibizumab is investigated as a possible new treatment for diabetic macular edema (DME). Diabetes Care
New Surgical Technique For Conjunctivochalasis?
Dr. Choi describes a very simple method in Ophthalmology of getting good results treating conjunctivochalasis.
Bausch + Lomb Initiates Phase 2b Study With Glaucoma Drug Candidate
NicOx S.A. today announced that its partner Bausch + Lomb has initiated a phase 2b clinical study with BOL-303259-X, previously known as NCX 116. BOL-303259-X is a nitric oxide-donating prostaglandin F2-alpha analog, which lowers intraocular pressure…
Santen Inc. Appoints Associate Director of Strategic Marketing
Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals, has announced the appointment of Yuan Chang as the Associate Director of Strategic Marketing.
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2010
WORCESTER, Mass.–(BUSINESS WIRE)–RXi Pharmaceuticals Corporation (Nasdaq: RXII) today reported its financial results for the third quarter ended September 30, 2010. RXi Pharmaceuticals is a recognized leader in RNAi-based therapeutic discovery and development with a comprehensive therapeutic platform that includes both…